Orchestra BioMed Holdings OBIO
NASDAQ OBIO
$6.23 +0.15 (+2.47%)
As of: Sep 30, 2026 · 3:18 PM EDT

Orchestra BioMed Holdings (OBIO) Convertible Debt (2026)

Updated

Orchestra BioMed Holdings' Convertible Debt was $20.44 million in Q2 2026.

Analysis

Orchestra BioMed Holdings (OBIO) Convertible Debt (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn
10 Orchestra BioMed Holdings 365.44 Mn -31.16 Mn 63,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 20.44 Mn
API Access

Orchestra BioMed Holdings Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=OBIO&period=max&api_key=YOUR_API_KEY